SREBF1 and metabolic dysfunction-associated steatotic liver disease: The cleaved form of SREBP1 is responsible for activating the expression of Pparg and other lipogenic enzymes that lead to the development of NAFLD (Figs. 2a, 3, 4, and 5b–f).